BA
GSK icon

Boston Advisors’s GSK GSK Stock Holding History

Boston Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-4,539
Closed -$262K – 664
2015
Q1 		$262K Buy
4,539
+251
+6% +$14.4K 0.01% 599
2014
Q4 		$229K Sell
4,288
-1,821
-30% -$102K 0.01% 539
2014
Q3 		$351K Buy
6,109
+280
+5% +$17.2K 0.01% 418
2014
Q2 		$390K Hold
5,829
– – 0.02% 408
2014
Q1 		$389K Sell
5,829
-933
-14% -$63.1K 0.02% 389
2013
Q4 		$451K Sell
6,762
-200
-3% -$13K 0.02% 356
2013
Q3 		$437K Buy
6,962
+48
+0.7% +$3.09K 0.02% 338
2013
Q2 		$432K Buy
+6,914
New +$439K 0.02% 333

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boston Advisors's GSK Position: Q2 2015 in Review

Boston Advisors sold out of GSK (GSK) in Q2 2015, closing a stake of 4,539 shares — an estimated $262K sold.

Boston Advisors first reported a position in GSK in Q2 2013 and held it in 8 quarters. The position peaked at $451K in Q4 2013. 719 funds tracked by Wall St. Rank hold GSK as of Q2 2015.

  • Boston Advisors reported no remaining GSK position as of Q2 2015 after selling out during the quarter.
  • Boston Advisors sold 4,539 GSK shares in Q2 2015, an estimated $262K.
  • Boston Advisors first reported a position in GSK in Q2 2013 and held it in 8 quarters.
  • Boston Advisors's GSK position peaked at $451K in Q4 2013.
  • 719 funds tracked by Wall St. Rank held GSK as of Q2 2015.

Based on Boston Advisors's 13F filing for Q2 2015, filed 22 Jul 2015.